For the quarter ended September 2025, GE HealthCare Technologies (GEHC) reported revenue of $5.14 billion, up 5.8% over the same period last year. EPS came in at $1.07, compared to $1.14 in the year-ago quarter.
The reported revenue represents a surprise of +1.48% over the Zacks Consensus Estimate of $5.07 billion. With the consensus EPS estimate being $1.05, the EPS surprise was +1.9%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how GE HealthCare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues- Imaging: $2.35 billion compared to the $2.29 billion average estimate based on four analysts. The reported number represents a change of +5.4% year over year.
- Revenues- AVS (Advanced Visualization Solutions): $1.3 billion compared to the $1.26 billion average estimate based on four analysts.
- Revenues- Other: $15 million compared to the $11.07 million average estimate based on four analysts. The reported number represents a change of 0% year over year.
- Revenues- PDx (Pharmaceutical Diagnostics): $749 million versus $709.54 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +19.8% change.
- Revenues- PCS (Patient Care Solutions): $731 million versus the four-analyst average estimate of $790.59 million. The reported number represents a year-over-year change of -6.2%.
View all Key Company Metrics for GE HealthCare here>>>
Shares of GE HealthCare have returned +5.7% over the past month versus the Zacks S&P 500 composite's +3.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
GE HealthCare Technologies Inc. (GEHC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
